Book contents
- Frontmatter
- Contents
- List of contributors
- Preface
- Part 1 Assessing and utilizing the diagnostic or prognostic power of biomarkers
- Part 2 Biomarkers of kidney disease and dysfunction
- Part 3 Biomarkers of bone disease and dysfunction
- Part 4 Biomarkers of liver disease and dysfunction
- Part 5 Biomarkers of gastrointestinal disease and dysfunction
- Part 6 Biomarkers in toxicology
- Part 7 Biomarkers of cardiovascular disease and dysfunction
- 31 The impact of biochemical tests on patient management
- 32 Cardiac natriuretic peptides in risk assessment of patients with acute myocardial infarction or congestive heart failure
- 33 Serum markers of inflammation and cardiovascular risk
- 34 The clinical significance of markers of coagulation in acute coronary syndromes
- 35 Endothelin: what does it tell us about myocardial and endothelial dysfunction?
- 36 Homocysteine: a reversible risk factor for coronary heart disease
- 37 Matrix metalloproteinases and their tissue inhibitors
- Part 8 Biomarkers of neurological disease and dysfunction
- Part 9 Biomarkers in transplantation
- Index
34 - The clinical significance of markers of coagulation in acute coronary syndromes
Published online by Cambridge University Press: 20 August 2009
- Frontmatter
- Contents
- List of contributors
- Preface
- Part 1 Assessing and utilizing the diagnostic or prognostic power of biomarkers
- Part 2 Biomarkers of kidney disease and dysfunction
- Part 3 Biomarkers of bone disease and dysfunction
- Part 4 Biomarkers of liver disease and dysfunction
- Part 5 Biomarkers of gastrointestinal disease and dysfunction
- Part 6 Biomarkers in toxicology
- Part 7 Biomarkers of cardiovascular disease and dysfunction
- 31 The impact of biochemical tests on patient management
- 32 Cardiac natriuretic peptides in risk assessment of patients with acute myocardial infarction or congestive heart failure
- 33 Serum markers of inflammation and cardiovascular risk
- 34 The clinical significance of markers of coagulation in acute coronary syndromes
- 35 Endothelin: what does it tell us about myocardial and endothelial dysfunction?
- 36 Homocysteine: a reversible risk factor for coronary heart disease
- 37 Matrix metalloproteinases and their tissue inhibitors
- Part 8 Biomarkers of neurological disease and dysfunction
- Part 9 Biomarkers in transplantation
- Index
Summary
Introduction
Arterial thrombus formation seems to be an important factor in the conversion of chronic to acute atherosclerotic coronary events after plaque rupture, in the progression of coronary disease and in the acute phase of revascularization interventions. The presence of intraluminal thrombi, both in unstable angina and in acute myocardial infarction, has been documented in pathological, angiographic, angioscopic and intravascular ultrasound studies. In contrast with the very high incidence of thrombi in acute myocardial infarction, its incidence in unstable angina varies significantly among different studies, related, in part, to the interval between the onset of symptoms and the angiographic study. Presumably, the thrombus is occlusive at the time of anginal pain and later may become subocclusive and slowly lysed or digested. Local and systemic thrombogenic risk factors at the time of coronary plaque disruption may influence the type of thrombus and, hence, the different pathological and clinical syndromes [1].
Thrombosis: platelets and coagulation
In severe injury, with exposure of components of the plaque, as in spontaneous plaque rupture or in angioplasty, marked platelet aggregation with mural thrombus formation follows. Vascular injury of this magnitude stimulates thrombin formation through both the intrinsic (surface-activated) and extrinsic (tissue factor-dependent) coagulation pathways, in which the platelet membrane facilitates interactions between clotting factors. This concept of vascular injury as a trigger of the platelet coagulation response is important in understanding the pathogenesis of the various vascular diseases associated with atherosclerosis and coronary artery disease.
- Type
- Chapter
- Information
- Biomarkers of DiseaseAn Evidence-Based Approach, pp. 355 - 364Publisher: Cambridge University PressPrint publication year: 2002